Medication DNA InsightSM

One of the great promises of genetic testing is personalized medicine – allowing physicians to deliver health care based on a person’s genotype. An individual’s genetics can suggest optimal dosing levels, cause some medications to be more or less effective, or in some cases lead to avoiding wrong medications that could cause personal harm. Pathway Genomics’ Medication DNA InsightSM indicates which medications are optimal for a person based on his or her genetics.

Even if a person is currently not taking any of the medications included in the test, the information may be very important to know in an emergency.

Pathway Genomics provides physicians and patients access to a genetic counselor at no charge to review individual results.

The Medication DNA InsightSM genetic test reports on the following medications and traits:

Abacavir hypersensitivity
Aminoglycoside antibiotics-induced hearing loss
Beta-blockers
Beta-blockers, LVEF response
Carbamazepine hypersensitivity
Clopidogrel metabolism
Estrogen supplementation
Interferon-alpha/ribavirin
Methotrexate toxicity
Metoprolol metabolism
Phenytoin hypersensitivity
Phenytoin metabolism
Proton pump inhibitors
Simvastatin-induced myopathy
Voriconazole metabolism
Warfarin

back to top